Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05198141Phase 4Completed
Phase 4, randomised, open-label trial of letrozole in Ectopic pregnancy (EP) (3 arms), sponsored by Zagazig University. Primary endpoint: Human Chorionic Gonadotropin at day 11. Started Dec 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05198141.